Dear customers, we would like to share with you the great news on the decision of the European Commission (14 Oct 2021) extending the deadlines for the implementation of the new IVDR (Regulation No. 2017/746) in order to avoid disruption of the supply of in vitro medical devices. According to the risk classes of IVD devices, the new terms are proposed according to the following table:
In Vitro Diagnostic Medical Devices Regulation (europa.eu) md_2017-746-regulation_2021-amendment_en.pdf (europa.eu)
Phagocytosis, the process where specialised cells of the immune system kill and decompose microorganisms (e.g. extracellular bacteria), is fundamental to innate non-specific human immunity. Polymorphonuclear leukocytes (neutrophilic granulocytes), macrophages and dendritic cells are the effector cells in the process of phagocytosis.
We are introducing a group of antibodies against cytoskeletal antigens that can be used as markers in neurobiology.